May 13, 2020 / 9:18 PM / 15 days ago

BRIEF-Viela Bio Experienced Minimal Effects On Our Business From Covid-19

May 13 (Reuters) - Viela Bio Inc:

* VIELA BIO REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROGRAM HIGHLIGHTS

* VIELA BIO INC - EXPERIENCED MINIMAL EFFECTS ON OUR BUSINESS FROM COVID-19

* VIELA BIO - ANNOUNCED POSITIVE INTERIM RESULTS FROM COHORTS OF PATIENTS WITH CUTANEOUS LUPUS ERYTHEMATOSUS IN OUR ONGOING PHASE 1B TRIAL OF VIB7734

* VIELA BIO INC - AS OF MARCH 31 HAD $335.2 MILLION IN CASH, CASH EQUIVALENTS, AND INVESTMENTS AND NO OUTSTANDING DEBT

* VIELA BIO INC - EXPECTS THAT ITS CASH, CASH EQUIVALENTS AND INVESTMENTS WILL FUND ITS OPERATING PLANS INTO MID-YEAR 2022 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below